BioCentury | Jan 1, 2007
Tools & Techniques

Genmab's Hand-me-down

...Genmab A/S plucked a bundle of cancer targets from the remains of former proteomics company Europroteome AG...
...Genmab (CSE:GEN, Copenhagen, Denmark) obtained the rights to ZP3A and 15 other undisclosed targets from Europroteome's...
...or royalties on products that result (see BioCentury, May 23, 2005). "ZP3 is the first Europroteome...
BioCentury | May 23, 2005
Company News

Europroteome, Genmab deal

...dependent cancers of epithelial cell origin, such as gastrointestinal cancers, from the insolvency administrator of Europroteome...
...milestone or royalty obligations. Europroteome filed for insolvency last August (see BioCentury, Aug. 23, 2004). Europroteome AG...
BioCentury | May 19, 2005
Company News

Genmab acquires cancer targets

...dependent cancers of epithelial cell origin, such as gastrointestinal cancers, from the insolvency administrator of Europroteome...
...colon carcinomas. The purchase price was not disclosed. GEN has no milestone or royalty obligations. Europroteome...
BioCentury | Aug 23, 2004
Company News

Europroteome diagnostic news

...it is in negotiations with potential buyers to sell all or parts of the company. Europroteome AG...
BioCentury | Aug 18, 2004
Company News

Europroteome files for insolvency

...targeting membrane proteins for cancer, has filed for insolvency. According to CFO Walter von Horstig, Europroteome...
...develop in vitro breast cancer diagnostics that run on ABT's automated instruments. Also in July, Europroteome...
BioCentury | Jul 19, 2004
Company News

Europroteome, Abbott deal

...instruments (see BioCentury, March 8). The expansion triggered and undisclosed milestone from ABT to Europroteome. Europroteome AG...
BioCentury | Mar 8, 2004
Company News

Europroteome, Abbott deal

...companies partnered to develop in vitro breast cancer diagnostics that run on ABT's automated instruments. Europroteome...
...samples. Identified markers will be combined with ABT's panel of cancer markers for diagnostic development. Europroteome...
...milestone payments, and ABT has an option to license resulting discoveries in exchange for royalties. Europroteome AG...
BioCentury | Mar 1, 2004
Company News

Europroteome, Abbott diagnostic deal

...companies partnered to develop in vitro breast cancer diagnostics that run on ABT's automated instruments. Europroteome...
...samples. Identified markers will be combined with ABT's panel of cancer markers for diagnostic development. Europroteome...
BioCentury | Jul 21, 2003
Company News

Europroteome, Intradigm deal

...Disease Control validation technology in animal tumor models to validate one of Europroteome's cancer targets. Europroteome AG...
BioCentury | Jul 17, 2003
Company News

Intradigm, Europroteome cancer deal

...Intradigm (Rockville, Md.) and Europroteome (Hennigsdorf, Germany) partnered to validate cancer targets using siRNA delivery in...
...use its siRNA-based Disease Control validation technology in animal models of cancer for one of Europroteome's...
Items per page:
1 - 10 of 31
BioCentury | Jan 1, 2007
Tools & Techniques

Genmab's Hand-me-down

...Genmab A/S plucked a bundle of cancer targets from the remains of former proteomics company Europroteome AG...
...Genmab (CSE:GEN, Copenhagen, Denmark) obtained the rights to ZP3A and 15 other undisclosed targets from Europroteome's...
...or royalties on products that result (see BioCentury, May 23, 2005). "ZP3 is the first Europroteome...
BioCentury | May 23, 2005
Company News

Europroteome, Genmab deal

...dependent cancers of epithelial cell origin, such as gastrointestinal cancers, from the insolvency administrator of Europroteome...
...milestone or royalty obligations. Europroteome filed for insolvency last August (see BioCentury, Aug. 23, 2004). Europroteome AG...
BioCentury | May 19, 2005
Company News

Genmab acquires cancer targets

...dependent cancers of epithelial cell origin, such as gastrointestinal cancers, from the insolvency administrator of Europroteome...
...colon carcinomas. The purchase price was not disclosed. GEN has no milestone or royalty obligations. Europroteome...
BioCentury | Aug 23, 2004
Company News

Europroteome diagnostic news

...it is in negotiations with potential buyers to sell all or parts of the company. Europroteome AG...
BioCentury | Aug 18, 2004
Company News

Europroteome files for insolvency

...targeting membrane proteins for cancer, has filed for insolvency. According to CFO Walter von Horstig, Europroteome...
...develop in vitro breast cancer diagnostics that run on ABT's automated instruments. Also in July, Europroteome...
BioCentury | Jul 19, 2004
Company News

Europroteome, Abbott deal

...instruments (see BioCentury, March 8). The expansion triggered and undisclosed milestone from ABT to Europroteome. Europroteome AG...
BioCentury | Mar 8, 2004
Company News

Europroteome, Abbott deal

...companies partnered to develop in vitro breast cancer diagnostics that run on ABT's automated instruments. Europroteome...
...samples. Identified markers will be combined with ABT's panel of cancer markers for diagnostic development. Europroteome...
...milestone payments, and ABT has an option to license resulting discoveries in exchange for royalties. Europroteome AG...
BioCentury | Mar 1, 2004
Company News

Europroteome, Abbott diagnostic deal

...companies partnered to develop in vitro breast cancer diagnostics that run on ABT's automated instruments. Europroteome...
...samples. Identified markers will be combined with ABT's panel of cancer markers for diagnostic development. Europroteome...
BioCentury | Jul 21, 2003
Company News

Europroteome, Intradigm deal

...Disease Control validation technology in animal tumor models to validate one of Europroteome's cancer targets. Europroteome AG...
BioCentury | Jul 17, 2003
Company News

Intradigm, Europroteome cancer deal

...Intradigm (Rockville, Md.) and Europroteome (Hennigsdorf, Germany) partnered to validate cancer targets using siRNA delivery in...
...use its siRNA-based Disease Control validation technology in animal models of cancer for one of Europroteome's...
Items per page:
1 - 10 of 31